Hypertension Patients Join Feud Over Pfizer's Norvasc
In a move that highlights the growing debate over the balance between the rights of poor nations and those of drug patent holders, a group of patients said on Friday it...To view the full article, register now.
Already a subscriber? Click here to view full article